These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 11818473)

  • 1. Diabetes and cardiovascular disease.
    Resnick HE; Howard BV
    Annu Rev Med; 2002; 53():245-67. PubMed ID: 11818473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the clinical usefulness of the metabolic syndrome? The Casale Monferrato study.
    Bruno G; Fornengo P; Segre O; Novelli G; Panero F; Perotto M; Zucco C; Bargero G; Cavallo-Perin P
    J Hypertens; 2009 Dec; 27(12):2403-8. PubMed ID: 19738492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.
    Haffner SM
    Am J Cardiol; 2006 Jan; 97(2A):3A-11A. PubMed ID: 16442931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease in diabetes.
    Zhang PY
    Eur Rev Med Pharmacol Sci; 2014; 18(15):2205-14. PubMed ID: 25070828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities.
    Khamaisi M; Wexler ID; Skrha J; Strojek K; Raz I; Milicevic Z
    Isr Med Assoc J; 2003 Nov; 5(11):801-6. PubMed ID: 14650106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
    van der Velde M; Bello AK; Brantsma AH; El Nahas M; Bakker SJ; de Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2012 Jun; 27(6):2275-83. PubMed ID: 22231032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking, diabetes and cardiovascular diseases in men in the Asia Pacific region.
    Kengne AP; Nakamura K; Barzi F; Lam TH; Huxley R; Gu D; Patel A; Kim HC; Woodward M;
    J Diabetes; 2009 Sep; 1(3):173-81. PubMed ID: 20923536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study.
    Penno G; Solini A; Bonora E; Fondelli C; Orsi E; Zerbini G; Trevisan R; Vedovato M; Gruden G; Laviola L; Nicolucci A; Pugliese G;
    J Intern Med; 2013 Aug; 274(2):176-91. PubMed ID: 23565931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].
    Minami J; Ishimitsu T; Sudo Y; Matsuoka H
    Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet & insulin resistance: a review & Asian Indian perspective.
    Isharwal S; Misra A; Wasir JS; Nigam P
    Indian J Med Res; 2009 May; 129(5):485-99. PubMed ID: 19675375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational diabetes mellitus: taking it to heart.
    Marcinkevage JA; Narayan KM
    Prim Care Diabetes; 2011 Jul; 5(2):81-8. PubMed ID: 21106447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood trauma and prevalence of cardiovascular disease in patients with type 1 diabetes.
    Roy A; Janal MN; Roy M
    Psychosom Med; 2010 Oct; 72(8):833-8. PubMed ID: 20668287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors (diabetes, hypertension, hypercholesterolemia and metabolic syndrome) in older people with intellectual disability: results of the HA-ID study.
    de Winter CF; Bastiaanse LP; Hilgenkamp TI; Evenhuis HM; Echteld MA
    Res Dev Disabil; 2012; 33(6):1722-31. PubMed ID: 22699246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome.
    Reaven P
    J Insur Med; 2004; 36(2):132-42. PubMed ID: 15301226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.